UNHLM a major opportunity to End TB
Burnet joins 'Midwifery Futures' workforce review
A COVID inquiry has been announced. But is COVID still a thing? Do I need a booster?
COVID is not a 'forever virus' but new tools are needed
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
"It is still very little; I cannot pass it on": a qualitative study of experienc...
Police drug seizures cannot solve the problem of toxic drug supply in North Amer...
The unfinished agenda of communicable diseases among children and adolescents be...
Robust immunity to influenza vaccination in haematopoietic stem cell transplant ...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Donating for Individuals
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Explore Burnet's progress and journey through this unique series of impact stories.
Burnet maintains a focus on developing and evaluating new interventions to address the most pressing...
Through the years, Burnet’s medical researchers and public health experts have continued to collabor...
Burnet’s innovative and evidence-based public health and laboratory-led COVID-19 research initiative...
Burnet’s experiences in Tibet and parts of China demonstrate a commitment to working with communitie...
Western Province is now making significant progress against TB. Despite ongoing challenges with drug...
In the 1990s, Burnet focused on reducing the risk of harm to PWID by introducing needle exchange pro...
In 2008, Cyclone Nargis hit Myanmar, causing upheaval in the lives of over 2 million people, and kil...
Burnet researchers have led significant discoveries that have proven pivotal in developing next gene...
Burnet now plays a key implementation role, leading an alliance of researchers, public health specia...
